论文信息 - Infusion reactions to the chimeric EGFR inhibitor cetuximab--change to the fully human anti-EGFR monoclonal antibody panitumumab is safe. - 字舞流文

Infusion reactions to the chimeric EGFR inhibitor cetuximab--change to the fully human anti-EGFR monoclonal antibody panitumumab is safe.

R. Greil | W. Scheithauer | T. Sliwa | T. Nösslinger | J. Thaler | P. Kier | R. Schaberl-Moser | B. Mayrbäurl | G. Kopetzky | G. Resch